FDA 483 - Genus Lifesciences Inc. - September 20, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Genus Lifesciences Inc. in Allentown, PA, was cited for significant deficiencies in its quality control systems during an FDA inspection. The firm failed to thoroughly investigate product discrepancies, including cloudiness, empty bottles, and mold contamination, and lacked adequate written procedures for production and process controls, particularly for packaging validation. Additionally, the company did not submit a required Field Alert Report within the specified timeframe for a significant product issue.
ID · c705deab-3810-428e-9d86-946cdbe44d35